// App-Quantinova.ai

37 GP19.08 : Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly

Researchers

Presenter

  • Ludovica F S Grasso

Principal Investigators

  • Mariano Galdiero

  • Claudia Pivonello

  • Ciro Salzano

  • Mariarosaria Negri

  • Cristina de Angelis

  • Annamaria Colao

  • Rosario Pivonello

Medical Centers

  • Dipartimento di Medicina Clinica e Chirurgia, Universit Federico II di Napoli, Naples, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diastolic dysfunction

  • Heart muscle disease

  • Acromegaly

Biomarkers

  • GC Vitamin D Binding Protein

  • Hemoglobin A1c

  • Insulin-like growth factor 1

  • Sex hormone binding globulin

  • Somatostatin

  • Body mass index

Drug/Treatment

  • Somatostatin

  • Pegvisomant

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final